Date Filed | Type | Description |
08/17/2023 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 36,183 shares
@ $3.14, valued at
$113.6k
Granted 210,175 shares
@ $0 |
|
08/17/2023 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 40,022 shares
@ $3.14, valued at
$125.7k
Granted 219,650 shares
@ $0 |
|
08/17/2023 |
4
| MOHANTY ADITYA P. (CEO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 117,881 shares
@ $3.14, valued at
$370.1k
Granted 559,450 shares
@ $0 |
|
06/16/2023 |
4
| Kotzin Brian L. (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Granted 12,500 shares
@ $0 Granted 12,500 options to buy
@ $4.7, valued at
$58.8k
|
|
06/16/2023 |
4
| Powell Lynne (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Granted 12,500 shares
@ $0 Granted 12,500 options to buy
@ $4.7, valued at
$58.8k
|
|
06/16/2023 |
4
| Alter Jeffrey D. (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Granted 12,500 shares
@ $0 Granted 12,500 options to buy
@ $4.7, valued at
$58.8k
|
|
06/16/2023 |
4
| Howe Jill Ann (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Granted 12,500 shares
@ $0 Granted 12,500 options to buy
@ $4.7, valued at
$58.8k
|
|
05/17/2023 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 2,807 shares
@ $3.35, valued at
$9.4k
|
|
05/17/2023 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 2,368 shares
@ $3.35, valued at
$7.9k
|
|
05/17/2023 |
4
| MOHANTY ADITYA P. (CEO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 11,249 shares
@ $3.35, valued at
$37.7k
|
|
03/17/2023 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Granted 57,950 shares
@ $0 Granted 21,684 shares
@ $0 Paid exercise price by delivering 10,683 shares
@ $2.56, valued at
$27.3k
|
|
03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2023 |
4
| Athyrium Opportunities III Co-Invest 1 LP (10% Owner) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Disposed/sold 42,362 shares
@ $0 |
|
01/05/2023 |
4
| Kotzin Brian L. (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Disposed/sold 44 shares
@ $0 |
|
01/05/2023 |
4
| MOHANTY ADITYA P. (CEO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Disposed/sold 178 shares
@ $0 |
|
01/05/2023 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Disposed/sold 44 shares
@ $0 |
|
01/05/2023 |
4
| Powell Lynne (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Disposed/sold 45 shares
@ $0 |
|
01/05/2023 |
4
| Alter Jeffrey D. (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Disposed/sold 65 shares
@ $0 |
|
01/05/2023 |
4
| Sarna Surbhi (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Disposed/sold 8 shares
@ $0 |
|
01/05/2023 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Disposed/sold 95 shares
@ $0 |
|
01/05/2023 |
4
| Howe Jill Ann (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Disposed/sold 19 shares
@ $0 |
|
11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/16/2022 |
4
| MOHANTY ADITYA P. (CEO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 175,071 shares
@ $0.27, valued at
$47.3k
|
|
11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2022 |
4
| Athyrium Opportunities III Co-Invest 1 LP (10% Owner) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Bought 12,506,250 shares
@ $0 Bought 12,506,250 options to buy
@ $0.33, valued at
$4.1M
Disposed/sold 8,097,166 warrants
@ $2.84, valued at
$23M
Granted 8,097,166 warrants
@ $0.33, valued at
$2.7M
|
|
08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/16/2022 |
4
| dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 5,952 shares
@ $1.04, valued at
$6.2k
|
|
07/05/2022 |
4
| Sarna Surbhi (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Sold 7,517 shares
@ $0.61, valued at
$4.6k
|
|
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
4
| Powell Lynne (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Granted 96,154 shares
@ $0 Granted 148,810 options to buy
@ $0.64, valued at
$95.2k
|
|
06/17/2022 |
4
| Sarna Surbhi (Director) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns:
| Granted 96,154 shares
@ $0 Granted 148,810 options to buy
@ $0.64, valued at
$95.2k
|
|
|